• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Amgen

Amgen

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. UPDATE: Apple shares drop as after-hour earnings loom

    UPDATE: Apple shares drop as after-hour earnings loom

  2. U.S. stocks: Futures fall as Caterpillar, 3M, durable goods line up

    U.S. stocks: Futures fall as Caterpillar, 3M, durable goods line up

  3. UPDATE: U.S. stocks: Futures fall as Caterpillar, 3M, durable goods line up

    UPDATE: U.S. stocks: Futures fall as Caterpillar, 3M, durable goods line up

  4. UPDATE: Apple, Pfizer, Yahoo earnings in focus

    UPDATE: Apple, Pfizer, Yahoo earnings in focus

  5. UPDATE: U.S. stocks: Futures fall as DuPont, Microsoft disappoint; durables ahead

    UPDATE: U.S. stocks: Futures fall as DuPont, Microsoft disappoint; durables ahead

  6. Research and Markets: Global Psoriasis Therapeutics Market 2015-2019 with Abbvie, Amgen , Janssen Pharmaceuticals & Pfizer Dominating

    Research and Markets: Global Psoriasis Therapeutics Market 2015-2019 with Abbvie, Amgen , Janssen Pharmaceuticals & Pfizer Dominating

  7. Opsona Therapeutics Ltd. Initiates a Prospective Open Label Phase I/II Study in Second-Line Lower (Low and Intermediate-1) Risk Myelodysplastic Syndrome (MDS) with OPN-305, a First-in Class ...

    Opsona Therapeutics Ltd. Initiates a Prospective Open Label Phase I/II Study in Second-Line Lower (Low and Intermediate-1) Risk Myelodysplastic Syndrome (MDS) with OPN-305, a First-in Class Monoclonal Antibody That Blocks Toll-Like Receptor 2

  8. UPDATE: Apple earnings, Fed vie for investor attention this week

    UPDATE: Apple earnings, Fed vie for investor attention this week

  9. MARKET SNAPSHOT: Apple Earnings, Fed Vie For Investor Attention This Week

    MARKET SNAPSHOT: Apple Earnings, Fed Vie For Investor Attention This Week

  10. UPDATE: Apple earnings, Fed vie for investor attention this week

    UPDATE: Apple earnings, Fed vie for investor attention this week

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.